Health Care & Life Sciences » Pharmaceuticals | Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $0.47
Market Cap
 $62.94 M
Shares Outstanding
 21.05 M
Public Float
 19.18 M

Profile

Address
12264 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.imprimispharma.com
Updated 09/14/2018
Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J.

Financials

View All
Created with Highcharts 5.0.14Imprimis Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.7 6437 64310 11810 11815 89915 89919 08719 08711 98511 9852013201420152016201705k10k15k20k25k
Created with Highcharts 5.0.14Imprimis Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.10101 6601 6609 7169 71619 94219 94226 77426 7742013201420152016201705k10k15k20k25k30k

Robert J. Kammer
Chairman
Mark L. Baum
Chief Executive Office & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.